Glenn Butcher is the CEO of FundWA, a venture capital firm focused on investing in technology-enabled innovation businesses in Western Australia.

In this interview, he discussed the potential for growth and success in this area, highlighting the state's strong track record in life sciences research and the potential for commercialising this research into products and services.

Butcher discussed the different types of organisations and products that might be of interest to investors in the life sciences sector, including drug development, medical devices, and digital therapeutics.

He emphasised the need for investment in this area, particularly in the form of early-stage funding, to support the development and commercialisation of these products.

Butcher also discussed the challenges and obstacles that can arise in the life sciences sector, including the need for regulatory approval and the importance of gaining the trust and support of the public.

He also talked about the role of the government in providing funding and support for the life sciences sector.

In conclusion, Butcher emphasised the potential for growth and success in the life sciences sector in Western Australia, highlighting the state's strong track record in this area and the potential for creating value and improving public health through the development and commercialisation of new products and services.